Innovation for lifeSofinnova

Purpose
People
Portfolio
Platforms
Press

Purpose
People
Portfolio
Platforms
Press
Careers
Contact
Investor Portal

Promedior

November 25, 2019

Share

file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/facebook.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/linkedin.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/twitter.svg

Promedior is a clinical-stage biotechnology company pioneering the development of Pentraxin-2 therapeutics to treat diseases involving fibrosis. (Acquired by Roche)

Share

file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/facebook.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/linkedin.svg
file does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/twitter.svg

3000 Sand Hill Rd
Building 3-Suite 150
Menlo Park, CA 94025
(650) 681-8420

One Marina Park Drive
Suite 300
Boston, MA 02210

27 West 24th Street
Suite 302
New York, NY 10010

© 2026 Sofinnova | Privacy Policy